California Providers Reach Antipsychotic Reduction Milestone

For Immediate Release
July 27, 2017

SACRAMENTO - According to a new report from the Centers for Medicare & Medicaid Services (CMS), California now ranks 5th best in the nation in reducing the use of antipsychotic medication in residents suffering from dementia.

This represents the highest level of achievement since the Partnership to Improve Dementia Care began its national campaign in 2012.

The CMS report shows that as of the first quarter of 2017, the use of antipsychotic medication in skilled nursing facilities in California was 12.3 percent, compared to the national average of 15.7 percent. Only four other states have lower antipsychotic usage including Hawaii, Alaska, the District of Columbia and New Jersey.

Since the beginning of the national partnership, California providers have achieved a 43 percent overall reduction in the unnecessary use of antipsychotic medication.